These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28050350)

  • 21. Extensive cutaneous hyperpigmentation caused by minocycline.
    Pepine M; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):292-5. PubMed ID: 8436641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline hyperpigmentation.
    Messner EJ; Finger DR; Crowe MA; Royer MC
    J Clin Rheumatol; 1999 Oct; 5(5):273-8. PubMed ID: 19078408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Minocycline-induced hyperpigmentation: not uncommon, but nonetheless important to recognise].
    Voets PJ; Blommaert D; Keijsers RR; Alkemade HA
    Ned Tijdschr Geneeskd; 2016; 160():D483. PubMed ID: 27879178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minocycline-induced hyperpigmentation involving the oral mucosa after short-term minocycline use.
    Filitis DC; Graber EM
    Cutis; 2013 Jul; 92(1):46-8. PubMed ID: 23961526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature.
    Treister NS; Magalnick D; Woo SB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jun; 97(6):718-25. PubMed ID: 15184854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline-induced hyperpigmentation of the tongue: successful treatment with the Q-switched ruby laser.
    Friedman IS; Shelton RM; Phelps RG
    Dermatol Surg; 2002 Mar; 28(3):205-9. PubMed ID: 11896769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma.
    Bell AT; Roman JW; Gratrix ML; Brzezniak CE
    Case Rep Oncol; 2017; 10(1):156-160. PubMed ID: 28413391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minocycline-induced skin pigmentation: an update.
    Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
    Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser.
    Greve B; Schönermark MP; Raulin C
    Lasers Surg Med; 1998; 22(4):223-7. PubMed ID: 9603284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy.
    Soung J; Cohen J; Phelps R; Cohen SR
    J Drugs Dermatol; 2007 Dec; 6(12):1232-6. PubMed ID: 18189065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe Type of Minocycline-Induced Hyperpigmentation Mimicking Peripheral Arterial Occlusive Disease in a Bullous Pemphigoid Patient.
    Wu MY; Hou YT; Yiang GT; Tsai AP; Lin CH
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31315305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy.
    Argenyi ZB; Finelli L; Bergfeld WF; Tuthill RJ; McMahon JT; Ratz JL; Petroff N
    J Cutan Pathol; 1987 Jun; 14(3):176-80. PubMed ID: 3611461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Black bone disease of the foot: a case study and review of literature demonstrating a correlation of long-term minocycline therapy and bone hyperpigmentation.
    Kerbleski GJ; Hampton TT; Cornejo A
    J Foot Ankle Surg; 2013; 52(2):239-41. PubMed ID: 23312403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minocycline hydrochloride hyperpigmentation complicating treatment of pyoderma gangrenosum.
    Miralles ES; Nuñez M; Pérez B; Ledo A
    J Dermatol; 1994 Dec; 21(12):965-7. PubMed ID: 7868770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin.
    Sato S; Murphy GF; Bernhard JD; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1981 Sep; 77(3):264-71. PubMed ID: 7264358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline hyperpigmentation isolated to the subcutaneous fat.
    Rahman Z; Lazova R; Antaya RJ
    J Cutan Pathol; 2005 Aug; 32(7):516-9. PubMed ID: 16008698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The histopathology of subcutaneous minocycline pigmentation.
    Bowen AR; McCalmont TH
    J Am Acad Dermatol; 2007 Nov; 57(5):836-9. PubMed ID: 17939935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minocycline and generalized cutaneous pigmentation.
    Simons JJ; Morales A
    J Am Acad Dermatol; 1980 Sep; 3(3):244-7. PubMed ID: 6450226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline.
    Bridges AJ; Graziano FM; Calhoun W; Reizner GT
    J Am Acad Dermatol; 1990 May; 22(5 Pt 2):959-62. PubMed ID: 2335590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.